{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:21:53Z","timestamp":1771917713324,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008644","name":"Faculty of Medicine, McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008644","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05074-9","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T02:21:56Z","timestamp":1739154116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Motti","family":"Haimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"3","key":"5074_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ejso.2007.07.209","volume":"34","author":"HL O\u2019Grady","year":"2008","unstructured":"O\u2019Grady HL, Conlon KC. Pancreatic neuroendocrine tumors. Eur J Surg Oncol. 2008;34(3):324\u201332. https:\/\/doi.org\/10.1016\/j.ejso.2007.07.209.","journal-title":"Eur J Surg Oncol"},{"key":"5074_CR2","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","volume":"135","author":"DC Metz","year":"2008","unstructured":"Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135:1469\u201392.","journal-title":"Gastroenterology"},{"key":"5074_CR3","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol"},{"key":"5074_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s12253-011-9382-y","volume":"17","author":"A Caldarella","year":"2011","unstructured":"Caldarella A, Crocetti E, Paci E. Distribution, incidence, and prognosis in neuroendocrine tumors: a population-based study from a cancer registry. Pathol Oncol Res. 2011;17:759\u201363.","journal-title":"Pathol Oncol Res"},{"key":"5074_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00534-006-1170-9","volume":"14","author":"RH Hruban","year":"2007","unstructured":"Hruban RH, Takaori K, Canto M, Fishman EK, Campbell K, Brune K, et al. Clinical importance of precursor lesions in the pancreas. J Hepatobiliary Pancreat Surg. 2007;14:255\u201363.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"5074_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000330212","volume":"11","author":"G Marchegiani","year":"2011","unstructured":"Marchegiani G, Crippa S, Malleo G, Partelli S, Capelli P, Pederzoli P, et al. Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. Pancreatology. 2011;11:383\u20139.","journal-title":"Pancreatology"},{"issue":"8","key":"5074_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/jhbp.226","volume":"22","author":"S Grozinsky-Glasberg","year":"2015","unstructured":"Grozinsky-Glasberg S, Mazeh H, Gross DJ. Clinical features of pancreatic neuroendocrine tumors. J Hepato-Biliary-Pancreatic Sci. 2015;22(8):578\u201385. https:\/\/doi.org\/10.1002\/jhbp.226.","journal-title":"J Hepato-Biliary-Pancreatic Sci"},{"key":"5074_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bpg.2012.12.003","volume":"26","author":"T Ito","year":"2012","unstructured":"Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol. 2012;26:737\u201353.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"5074_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/02841868909111209","volume":"28","author":"B Eriksson","year":"1989","unstructured":"Eriksson B, Oberg K, Skogseid B. Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients. Acta Oncol. 1989;28:373\u20137.","journal-title":"Acta Oncol"},{"key":"5074_CR10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1053\/j.seminoncol.2010.10.014","volume":"37","author":"K Oberg","year":"2010","unstructured":"Oberg K. Pancreatic endocrine tumors. Semin Oncol. 2010;37:594\u2013618.","journal-title":"Semin Oncol"},{"key":"5074_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","volume":"39","author":"MH Kulke","year":"2010","unstructured":"Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010;39:735\u201352.","journal-title":"Pancreas"},{"key":"5074_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00428-010-0924-6","volume":"456","author":"G Kloppel","year":"2010","unstructured":"Kloppel G, Rindi G, Perren A, Komminoth P, Klimstra DS. The ENETS and AJCC\/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch. 2010;456:595\u20137.","journal-title":"Virchows Arch"},{"key":"5074_CR13","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/annonc\/mdq022","volume":"21","author":"R Garcia-Carbonero","year":"2010","unstructured":"Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, Diaz-Perez JA, Martinez Del Prado MP, Alonso Orduna V, et al. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol. 2010;21:1794\u2013803.","journal-title":"Ann Oncol"},{"key":"5074_CR14","first-page":"573","volume":"63","author":"JA Madura","year":"1997","unstructured":"Madura JA, Cummings OW, Wiebke EA, Broadie TA, Goulet RL Jr, Howard TJ. Nonfunctioning islet cell tumors of the pancreas: a difficult diagnosis but one worth the effort. Am Surg. 1997;63:573\u20137; discussion 577-578.","journal-title":"Am Surg"},{"key":"5074_CR15","doi-asserted-by":"publisher","first-page":"E627","DOI":"10.1210\/jc.2011-2592","volume":"97","author":"G Kanakis","year":"2012","unstructured":"Kanakis G, Kaltsas G, Granberg D, Grimelius L, Papaioannou D, Tsolakis AV, et al. Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia. J Clin Endocrinol Metab. 2012;97:E627\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5074_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/ijc.2910460311","volume":"46","author":"R Rizzoli","year":"1990","unstructured":"Rizzoli R, Sappino AP, Bonjour JP. Parathyroid hormone-related protein and hypercalcemia in pancreatic neuro-endocrine tumors. Int J Cancer. 1990;46(3):394\u20138. https:\/\/doi.org\/10.1002\/ijc.2910460311.","journal-title":"Int J Cancer"},{"issue":"1","key":"5074_CR17","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2169\/internalmedicine.50.5357","volume":"50","author":"K Shirai","year":"2011","unstructured":"Shirai K, Inoue I, Kato J, Maeda H, Moribata K, Shingaki N, et al. A case of a giant glucagonoma with parathyroid hormone-related peptide secretion showing an inconsistent postsurgical endocrine status. Internal Med. 2011;50(1):1689\u2013894. https:\/\/doi.org\/10.2169\/internalmedicine.50.5357.","journal-title":"Internal Med"},{"key":"5074_CR18","unstructured":"Kremer R, Goltzman D. Parathyroid hormone related peptide (PTHrP) and other mediators of skeletal manifestations of malignancy. In: Bilezikian JP, Martin TJ, Clemens TL, Clifford CJ, editors. Principle of bone biology. eBook ISBN: 9780128148426."},{"issue":"2","key":"5074_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0002-9343(03)00310-3","volume":"115","author":"NY Truong","year":"2003","unstructured":"Truong NY, deB Edwardes M, Papavasiliou V, Goltzman D, Kremer R. Parathyroid hormone related peptide and survival of patients with cancer and hypercalcemia. Am J Med. 2003;115(2):115\u201321.","journal-title":"Am J Med"},{"issue":"1","key":"5074_CR20","first-page":"063","volume":"4","author":"G Assaker","year":"2020","unstructured":"Assaker G, Camirand A, Abdulkarim B, Omeroglu A, Deschenes J, Joseph K, Noman ASM, Ramana Kumar AV, Kremer R, Sabri S. PTHrP, a biomarker for CNS metastasis and node-negative adjuvant chemotherapy-selection in triple-negative breast cancer). J Natl Cancer Inst Cancer Spectrum. 2020;4(1):063.","journal-title":"J Natl Cancer Inst Cancer Spectrum."},{"issue":"7","key":"5074_CR21","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1158\/2159-8290.cd-20-1098","volume":"11","author":"JR Pitarresi","year":"2021","unstructured":"Pitarresi JR, Norgard RJ, Chiarella AM, Suzuki K, Bakir B, Sahu V, Li J, Zhao J, Marchand B, Wengyn MD, Hsieh A, Kim IK, Zhang A, Sellin K, Lee V, Takano S, Miyahara Y, Ohtsuka M, Maitra A, Notta F, Kremer R, Stanger BZ, Rustgi AK. PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability. Cancer Discov. 2021;11(7):1774\u201391. https:\/\/doi.org\/10.1158\/2159-8290.cd-20-1098.","journal-title":"Cancer Discov"},{"key":"5074_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1385\/EP:14:4:303","volume":"14","author":"RA DeLellis","year":"2003","unstructured":"DeLellis RA, Xia L. Paraneoplastic endocrine syndromes: a review. Endocr Pathol. 2003;14:303\u201317.","journal-title":"Endocr Pathol"},{"key":"5074_CR23","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1677\/ERC-10-0024","volume":"17","author":"G Kaltsas","year":"2010","unstructured":"Kaltsas G, Androulakis II, de Herder WW, Grossman AB. Paraneoplastic syndromes secondary to neuroendocrine tumours. Endocr Relat Cancer. 2010;17:R173\u201393.","journal-title":"Endocr Relat Cancer"},{"key":"5074_CR24","doi-asserted-by":"crossref","unstructured":"Grunbaum A, Kremer R. Parathyroid hormone-related protein (PTHrP) and malignancy. In: Litwack G, editor. Parathyroid hormone (the \u201cVolume\u201d). Vitamins and hormones. Elsevier Inc. San Diego, CA; 2022.","DOI":"10.1016\/bs.vh.2022.03.002"},{"key":"5074_CR25","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/annonc\/mdn351","volume":"19","author":"TR Halfdanarson","year":"2008","unstructured":"Halfdanarson TR, Rabe KG, Rubin J, et al. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008;19:1727\u201333.","journal-title":"Ann Oncol"},{"issue":"4","key":"5074_CR26","doi-asserted-by":"publisher","first-page":"E84","DOI":"10.3978\/j.issn.2078-6891.2014.042","volume":"5","author":"V Zhu","year":"2014","unstructured":"Zhu V, de Las MA, Janicek M, Hartshorn K. Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin D. J Gastrointest Oncol. 2014;5(4):E84\u20137. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2014.042.","journal-title":"J Gastrointest Oncol"},{"issue":"13","key":"5074_CR27","doi-asserted-by":"publisher","first-page":"1197288","DOI":"10.3389\/fonc.2023.1197288","volume":"12","author":"S Pitts","year":"2023","unstructured":"Pitts S, Mahipal A, Bajor D, Mohamed A. Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): case report. Front Oncol. 2023;12(13):1197288. https:\/\/doi.org\/10.3389\/fonc.2023.1197288.","journal-title":"Front Oncol"},{"issue":"07","key":"5074_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-2001-17411","volume":"109","author":"P Clemens","year":"2001","unstructured":"Clemens P, Gregor M, Lamberts R. Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)-associated hypercalcemia of malignancy. Exp Clin Endocrinol Diabetes. 2001;109(07):378\u201385. https:\/\/doi.org\/10.1055\/s-2001-17411.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"5074_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-112-7-499","volume":"112","author":"SH Ralston","year":"1990","unstructured":"Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Internal Med. 1990;112(7):499\u2013504. https:\/\/doi.org\/10.7326\/0003-4819-112-7-499.","journal-title":"Ann Internal Med"},{"issue":"12","key":"5074_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.4065\/72.12.1111","volume":"72","author":"TJ Wu","year":"1997","unstructured":"Wu TJ, Lin CL, Taylor RL, Kvols LK, Kao PC. Increased parathyroid hormone-related peptide in patients with hypercalcemia associated with islet cell carcinoma. Mayo Clinic Proc. 1997;72(12):1111\u20135. https:\/\/doi.org\/10.4065\/72.12.1111.","journal-title":"Mayo Clinic Proc"},{"issue":"3","key":"5074_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pan.2013.02.007","volume":"13","author":"A Milanesi","year":"2013","unstructured":"Milanesi A, Yu R, Wolin EM. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors: report of six cases. Pancreatology. 2013;13(3):324\u20136. https:\/\/doi.org\/10.1016\/j.pan.2013.02.007.","journal-title":"Pancreatology"},{"issue":"9","key":"5074_CR32","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1210\/jc.2014-1315","volume":"99","author":"K Kamp","year":"2014","unstructured":"Kamp K, Feelders RA, van Adrichem RCS, de Rijke YB, van Nederveen FH, Kwekkeboom DJ, et al. Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up. J Clin Endocrinol Metab. 2014;99(9):3060\u20139. https:\/\/doi.org\/10.1210\/jc.2014-1315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5074_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/136518201753242253","volume":"3","author":"IM Papazachariou","year":"2001","unstructured":"Papazachariou IM, Virlos IT, Williamson RCN. Parathyroid hormone-related peptide in pancreatic neuroendocrine tumours associated with hypercalcaemia. HPB (Oxford). 2001;3(3):221\u20135. https:\/\/doi.org\/10.1080\/136518201753242253.","journal-title":"HPB (Oxford)"},{"issue":"8","key":"5074_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jhbp.227","volume":"22","author":"H Igarashi","year":"2015","unstructured":"Igarashi H, Hijioka M, Lee L, Ito T. Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs. J Hepato-Biliary-Pancreatic Sci. 2015;22(8):618\u201322. https:\/\/doi.org\/10.1002\/jhbp.227.","journal-title":"J Hepato-Biliary-Pancreatic Sci"},{"issue":"3","key":"5074_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin ME, Pavel M, \u0106wik\u0142a JB, Phan AT, Raderer M, Sedl\u00e1\u010dkov\u00e1 E, et al. Lanreotide in metastatic enteropancreatic neuroendocrine. N Engl J Med. 2014;371(3):224\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1316158.","journal-title":"N Engl J Med"},{"issue":"6","key":"5074_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1634\/theoncologist.2015-0470","volume":"21","author":"RA Ramirez","year":"2016","unstructured":"Ramirez RA, Beyer DT, Chauhan A, Boudreaux JP, Wang YZ, Woltering EA. The role of capecitabine\/temozolomide in metastatic neuroendocrine tumors. Oncol. 2016;21(6):671\u20135. https:\/\/doi.org\/10.1634\/theoncologist.2015-0470.","journal-title":"Oncol"},{"issue":"2","key":"5074_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa1607427","volume":"376","author":"J Strosberg","year":"2017","unstructured":"Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125\u201335. https:\/\/doi.org\/10.1056\/NEJMoa1607427.","journal-title":"N Engl J Med"},{"issue":"18","key":"5074_CR38","doi-asserted-by":"publisher","first-page":"9269","DOI":"10.1021\/acs.analchem.6b02637","volume":"88","author":"BA Otieno","year":"2016","unstructured":"Otieno BA, Krause CE, Jones AL, Kremer RB, Rusling JF. Cancer diagnostics via ultrasensitive multiplexed detection of parathyroid hormone-related peptides with a microfluidic immunoarray. Anal Chem. 2016;88(18):9269\u201375.","journal-title":"Anal Chem"},{"issue":"37","key":"5074_CR39","doi-asserted-by":"publisher","first-page":"12788","DOI":"10.1021\/acs.analchem.2c02648","volume":"94","author":"L Dhanapala","year":"2022","unstructured":"Dhanapala L, Joseph S, Jones AL, Moghaddam S, Lee N, Kremer RB, Rusling JF. Immunoarray measurements of parathyroid hormone-related peptides combined with other biomarkers to diagnose aggressive prostate cancer. Anal Chem. 2022;94(37):12788\u201397. https:\/\/doi.org\/10.1021\/acs.analchem.2c02648.","journal-title":"Anal Chem"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05074-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T02:22:01Z","timestamp":1739154121000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05074-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5074"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05074-9","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}